A regulatory standards expert describes a patchwork system, the need for consistent rules to protect consumers, and the need for research to properly set those rules.
The CDC on Friday confirmed a decline in reports of vaping-related lung illnesses.
A new brewing process could not only be more cost-effective than cannabis cultivation, but could allow scientists to access possibly beneficial compounds that are present at lower levels in the plant.
“This will meet the need created by the increase in the amount of approved research involving marijuana,” the DEA told Cannabis Wire.
The ACS now has more than 300 members focused on researching cannabis, but there may be a need for more expansion.
Is the DEA Opening a Door to Cannabis Cultivation for Research? Or Is It Continuing to Drag Its Feet?
The agency says it will respond to pending applications, but first it will propose new regulations—without a timeline.
A university researcher needs veterans as subjects for his work on PTSD. He says the VA is making recruitment difficult.
A recent cannabis and opioid study highlighted that “corporate actors” with “deep pockets have substantial ability to promote congenial results, as suffering people are desperate for effective solutions.”
Q&A: After a survey shows a hunger for answers among clinicians and patients alike, a foundation gathers experts to chart a research path. Here’s why.
Studies are scarce, but one shows that prenatal exposure may lead to behavioral problems in children.
Katexco is moving forward with the development of its first potential cannabis-based therapies this year.
The Research Director of UCLA's Cannabis Research Initiative talks opioids, how men and women experience cannabis differently, and Alex Berenson's misrepresentation of cannabis research.
The three-day conference is an unprecedented gathering of leading public health experts to discuss future cannabis policy.
Here’s a list of 12 published studies and pieces of research that I found interesting or important since Cannabis Wire launched in June.
Until now, only synthetic cannabinoid-based medicines have been approved